Literature DB >> 27803545

Paraneoplastic Cerebellar Degeneration-A Rare Presentation of Ovarian Malignancy.

Richa Sharma1, Gita Radhakrishnan2, A G Radhika2, Anshuja Singla2.   

Abstract

Entities:  

Year:  2015        PMID： 27803545      PMCID： PMC5080230          DOI： 10.1007/s13224-015-0747-0

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN： 0975-6434


× No keyword cloud information.
  7 in total

1.  Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report.

Authors:  V Aruna Kumari; Prerna Gupta; M V Padma Srivastava; Lalit Kumar; Alka Kriplani; Neerja Bhatla
Journal:  J Obstet Gynaecol Res       Date:  2014-04-02       Impact factor: 1.730

Review 2.  Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.

Authors:  Y Cao; J Abbas; X Wu; J Dooley; A L van Amburg
Journal:  Gynecol Oncol       Date:  1999-10       Impact factor: 5.482

Review 3.  Paraneoplastic cerebellar degeneration.

Authors:  J B Posner
Journal:  Can J Neurol Sci       Date:  1993-05       Impact factor: 2.104

4.  Rehabilitation treatment options for a patient with paraneoplastic cerebellar degeneration.

Authors:  Erica Perlmutter; Patricia C Gregory
Journal:  Am J Phys Med Rehabil       Date:  2003-02       Impact factor: 2.159

5.  Paraneoplastic cerebellar degeneration caused by ovarian clear-cell carcinoma.

Authors:  Y Negishi; K Sakai; Y Noguchi; N Iwasaki; N Kawai
Journal:  J Obstet Gynaecol Res       Date:  2013-10-22       Impact factor: 1.730

6.  CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration.

Authors:  Tilo W Eichler; Cecilie Totland; Mette Haugen; Tor H Qvale; Kibret Mazengia; Anette Storstein; Bjørn I Haukanes; Christian A Vedeler
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

7.  Paraneoplastic cerebellar degeneration associated with ovarian cancer.

Authors:  Alessia Erika Russo; Simona Scalone; Giulia Costanza Leonardi; Aurora Scalisi; Giorgio Giorda; Roberto Sorio
Journal:  Oncol Lett       Date:  2012-11-07       Impact factor: 2.967
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.